-
81
Treat-to-target in rheumatoid arthritis: Clinical and pharmacoeconomic considerations
Published 2012Journal article -
82
-
83
THE PROBLEM OF OBESITY AND OVERWEIGHT IN THE RUSSIAN FEDERATION AND ITS PHARMACOECONOMIC ASSESSMENT
Published 2016-02-01Get full text
Article -
84
The issues of safety and pharmacoeconomics in the management of chronic pain in the back and limbs
Published 2011-06-01“…The paper reviews the data available in the literature on adverse reactions occurring with the use of NSAIDs, discusses the issues of pharmacoeconomics in the administration of various NSAIDs. …”
Get full text
Article -
85
REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS
Published 2015-09-01Subjects: “…pharmacoeconomics…”
Get full text
Article -
86
PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT
Published 2016-04-01Subjects: Get full text
Article -
87
PHARMACOECONOMICS AS A TOOL TO ENHANCE EFFICENCY OF HEALTH CARE SERVICES
Published 2017-11-01“…Pharmacoeconomics identifies, measures, and compares the costs and consequences of drug therapy to health care systems and society. …”
Get full text
Article -
88
PHARMACOECONOMIC EFFICIENCY OF QUADRIVALENT VACCINE TO PREVENT HPV-ASSOCIATED DISEASES
Published 2016-12-01Get full text
Article -
89
Pharmacoeconomic aspects of poor adherence to treatment in multiple sclerosis management
Published 2011-09-01Get full text
Article -
90
PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION
Published 2015-06-01Get full text
Article -
91
Pharmacoeconomic analysis of alogliptin use in the treatment of type 2 diabetes
Published 2018-05-01“…Aim of the study: Determine the validity of alogliptin choice in comparison with other DPP-4 inhibitors, available in Russia (saxagliptin, linagliptin, vildagliptin, sitagliptin) for add-on treatment in patients with inadequate glycemic control on metformin monotherapy, basing on pharmacoeconomic analysis Methodology. Retrospective modeling was performed according to standard pharmacoeconomic methods: cost-minimization analysis, cost-effectiveness analysis (CEA), cost-utility analysis (CUA) and sensitivity analyzes. …”
Get full text
Article -
92
Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus
Published 2018-11-01Subjects: Get full text
Article -
93
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review
Published 2020-11-01Subjects: Get full text
Article -
94
Pharmacoeconomic aspects of bronchial asthma therapy: real clinical practice
Published 2018-10-01Subjects: Get full text
Article -
95
Pharmacoeconomic evaluation of cefaclor in the pharyngo-tonsillitis and acute otitis in children
Published 2006-03-01Get full text
Article -
96
Pharmacoeconomical concept in the Book of Rhazes, 10th Century AD
Published 2019-01-01Get full text
Article -
97
Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
Published 2018-05-01Subjects: Get full text
Article -
98
Pharmacoeconomic analysis of botulinum toxin in complex therapy for cerebral palsy
Published 2018-06-01“…We have performed the fi rst-ever pharmacoeconomic analysis in a Russian context of botulin toxin drugs as part of combined therapy for juvenile cerebral palsy (JCP) compared to standard clinical practice. …”
Get full text
Article -
99
PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
Published 2015-09-01Subjects: Get full text
Article -
100
Automation of pharmacoeconomic evaluation of the rationality of prescribing and its today’s relevance
Published 2014-12-01Get full text
Article